Amir Kumar Singh

Employment

• Nanoscope Therapeutics Inc Senior Scientist
  2023 - Present
• UTSouthwestern Medical Center Reseach Scientist
  2019 - 2023
• Baylor Institute for Immunology Research Postdoc Fellow
  2016 - 2019
• National Institute of Immunology Research Associate
  2014 - 2016

Education

• Jawaharlal Nehru University Ph.D
  2007 - 2014
• Jawaharlal Nehru University M.Sc (Biotechnology)
  2005 - 2007
• Banaras Hindu University B.Sc (Agriculture)
  2001 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
  The Journal of Immunology 2021 DOI: 10.4049/jimmunol.2000015
  +Save
• Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function
  Journal for ImmunoTherapy of Cancer 2021
  +Save
• SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2
  Nature Communications 2018 DOI: 10.1038/s41467-018-06924-5
  +Save
• IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5
  Mucosal Immunology 2017 DOI: 10.1038/mi.2017.53
  +Save
• CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53‐mediated trans‐repression of β‐secretase
  Aging Cell 2015 DOI: 10.1111/acel.12335
  +Save
• p53 Amino-Terminus Region (1–125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype
  PLoS ONE 2009 DOI: 10.1371/journal.pone.0007159
  +Save